drugset / Trial / NCT01963208
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs).
Timeline
- Start
- 2013-10
- Primary completion
- 2016-05
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganaxolone | Small molecule | 1200 mg | — |
| Subject | Ganaxolone | Small molecule | 1800 mg | — |